Idibell

Spain Founded: 2004 • Age: 22 yrs
Provider of biomedical research services focusing on cancer, neuroscience, and regenerative medicine

About Idibell

Idibell is a Healthcare company based in Spain founded in 2004. Provider of biomedical research services focusing on cancer, neuroscience, and regenerative medicine. Its website idibell.cat draws about 23 thousand monthly visits. Idibell offers products and services including Research Services and Innovation Services. Its focus areas include Medical Research Labs. Its legal entity is Institut d’Investigació Biomèdica de Bellvitge.

Company details

Founded in 2004 in Spain, biomedical research services are provided by the organization, with a focus on cancer, neuroscience, and regenerative medicine. Translational research is conducted to bridge laboratory findings and patient care. Collaborative projects are supported, alongside scientific dissemination and training programs. Partnerships with other institutions are fostered within the scientific community.

Key Metrics
  • Latest Funding Round
    $128.97K (USD), Grant

    Sep 2022

  • Investors

Products & Services of Idibell

Idibell offers a comprehensive portfolio of products and services, including Research Services and Innovation Services.

Research Services
Biomedical Research

Research services in areas like cancer and neurosciences are provided to advance medical knowledge and health improvements.

Innovation Services
Translational Medicine

Innovation services from laboratory to patient applications are offered to bridge research and practical health solutions.

Apps and channels of Idibell

its YouTube channel IDIBELL has 571 subscribers and 30 videos.

IDIBELL
YouTube 571 subscribers 30 videos Science & Technology
Open channel

Videos from Idibell

The most watched videos on Idibell's YouTube channel, IDIBELL (571 subscribers). Click a video to play it here.

IDIBELL. Recerca biomèdica que canvia vides.
1.6K views
#StandUpScience Saioa Mendizuri - Fent visible allò invisible
574 views
Els serveis cientifico-tècnics de l'IDIBELL
445 views
#RecercaQueCanviaVides: El pacient, al centre de la nostra recerca
443 views

More on IDIBELL.

Funding Insights of Idibell

  • Total Rounds 26
  • Last Round Grant — $128,967
  • Investors Count 2

Latest 10 of 26 funding rounds of Idibell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2022$128,967Grant––
Feb 2022$181,900Grant––
Sep 2021$190,668Grant––
Jun 2021$211,779Grant––
Feb 2021$181,353Grant––
Sep 2020$191,877Grant––
Mar 2020$177,446Grant––
Jan 2019$194,973Grant––
Sep 2018$183,958Grant––
Sep 2018$183,657Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Idibell

Idibell has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
hhs.gov
Premium access

Investor details for Idibell

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Idibell

3 dated milestones of Idibell across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded Idibell is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $129K.

Web traffic of Idibell

The website of Idibell (idibell.cat) receives about 23.4K visits a month.

  • Monthly visits
    23.4K

    ▲ 10.7% vs previous month

Similar websites

Websites whose visitors overlap most with Idibell. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bellvitgehospital.cat
bellvitgehospital.cat
100%
#429,425–
fefoc.org
fefoc.org
87%
#10,180,472–
agsjerez.es
agsjerez.es
68%
#1,730,189–
says.isciii.es
says.isciii.es
66%
–
som360.org
som360.org
64%
#320,652–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 9 similar websites and full traffic analytics for Idibell

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Idibell

Idibell was founded in 2004 and raised its 1st funding round 6 years after it was founded.

Idibell is headquartered in Spain.

Founded in 2004 in Spain, biomedical research services are provided by the organization, with a focus on cancer, neuroscience, and regenerative medicine. Translational research is conducted to bridge laboratory findings and patient care. Collaborative projects are supported, alongside scientific dissemination and training programs. Partnerships with other institutions are fostered within the scientific community.

Idibell offers Research Services and Innovation Services.

Idibell has 2 investors. Key investors include European Union, and HHS.

Idibell operates through Institut D’Investigació Biomèdica De Bellvitge.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available